Evaluation of a New Multi-modality Visualization Tool for Investigation of Breast Lesions
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast Lesions
- Sponsor
- Sunnybrook Health Sciences Centre
- Enrollment
- 10
- Locations
- 1
- Primary Endpoint
- Target identification success: this outcome measure is a 'yes/no' outcome, indicating whether or not an MRI-detected lesion could be successfully visualized using US-guidance in the supplemental US exam
- Status
- Terminated
- Last Updated
- 14 years ago
Overview
Brief Summary
Magnetic resonance imaging (MRI) is commonly used for the detection of breast lesions in genetically high-risk women due to its high sensitivity. As non-cancerous conditions including normal changes due to a woman's menstrual cycle may have the appearance of cancer on MR images, a biopsy (generally performed under ultrasound-guidance) of the suspicious mass is required for definitive diagnosis. However, only a limited percentage of MRI-visible lesions are also visible on ultrasound (US). Even if found, it is often unclear whether the lesion identified on US corresponds to the MRI-detected lesion in question. The investigators have developed a visualization tool to assist the visualization of MRI-detected lesions in US-guided procedures (e.g., biopsy). This tool provides a simultaneous display of the previously acquired MRI data alongside real-time US images. The investigators propose a pilot study to assess the usefulness of this tool in identifying MRI-detected lesions using real-time US-guidance.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with MRI-identified lesions that cannot be visualized under the second-look ultrasound examination, and who will undergo the recommended unilateral MRI follow-up.
Exclusion Criteria
- •US-visible lesion.
- •Any contraindications to MRI (e.g., pacemakers, metal implants).
- •Any contraindications to US imaging.
- •Pregnancy.
- •Claustrophobia.
- •Inability to lie still for 45 minutes-1 hour.
- •In excess of 250 pounds.
- •Incapability to provide informed consent.
Outcomes
Primary Outcomes
Target identification success: this outcome measure is a 'yes/no' outcome, indicating whether or not an MRI-detected lesion could be successfully visualized using US-guidance in the supplemental US exam
Time Frame: Time of examination
Secondary Outcomes
- Confidence scale for lesion visualization This is a 5-point scale: 1 - very low confidence; 2 - low confidence; 3 - ambiguous; 4 - confident; 5 - very confident(Time of examination)